Kepos Capital’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Kepos Capital’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-200,000	Closed	-$138K	–	557
2020 Q4	$138K	Buy	+200,000	New	+$426K	0.01%	306

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Kepos Capital's BMY.RT Position: Q1 2021 in Review

Kepos Capital sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 200,000 shares — an estimated $138K sold.

Kepos Capital first reported a position in BMY.RT in Q4 2020 and held it in 1 quarter. The position peaked at $138K in Q4 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

Kepos Capital reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
Kepos Capital sold 200,000 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $138K.
Kepos Capital first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2020 and held it in 1 quarter.
Kepos Capital's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $138K in Q4 2020.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Kepos Capital's 13F filing for Q1 2021, filed 13 May 2021.